Clinical Trials List
Protocol NumberNN2211-1436
2006-05-01 - 2007-06-01
Phase III
Terminated3
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 呂金盈 無
- - - 無
- CHIH-YUAN WANG 無
- CHIH-YUAN WANG CHIH-YUAN WANG 無
- 張恬君 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1026 participants
